The clinical efficacy and adverse effects of Entecavir plus Thymosin alpha-1 combination therapy versus Entecavir Monotherapy in HBV-related cirrhosis: a systematic review and meta-analysis

Previous studies have demonstrated the benefits of thymosin alpha-1 (T α1) in anti-virus, immunological enhancement and anti-inflammation. However, it is controversial about the efficacy and safety of entecavir...

Source: BMC Gastroenterology - October 19, 2020 Category: Gastroenterology Authors: Dan Peng, Hai-Yan Xing, Chen Li, Xian-Feng Wang, Min Hou, Bin Li and Jian-Hong Chen Tags: Research article Source Type: research